Detalhe da pesquisa
1.
Measuring coping in multiple sclerosis: The Coping Index-MS.
Mult Scler
; 28(14): 2274-2284, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36000480
2.
Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial.
Age Ageing
; 49(6): 1003-1010, 2020 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-32318695
3.
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.
Mult Scler
; 25(11): 1462-1471, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30141723
4.
Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR Angiography.
Radiology
; 287(3): 795-804, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29714681
5.
Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain.
Eur J Nucl Med Mol Imaging
; 43(12): 2201-2210, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27349244
6.
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
BMC Neurol
; 15: 72, 2015 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-25935418
7.
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Neurology
; 100(3): e308-e323, 2023 01 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36192175
8.
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Immunology
; 137(4): 317-25, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23039207
9.
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).
J Neuroinflammation
; 9: 1, 2012 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-22212381
10.
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression.
J Neurol
; 269(6): 3226-3237, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35066607
11.
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.
Neurol Neuroimmunol Neuroinflamm
; 9(6)2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36038263
12.
Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study.
BMJ Open
; 11(6): e048788, 2021 06 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34135052
13.
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series.
Neurology
; 97(9): e890-e901, 2021 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34253634
14.
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Neurology
; 97(19): e1870-e1885, 2021 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34610987
15.
WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis.
Cochrane Database Syst Rev
; (6): CD004193, 2015 Jun 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26043867
16.
Aging, Cellular Senescence, and Progressive Multiple Sclerosis.
Front Cell Neurosci
; 14: 178, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32694983
17.
Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry study.
Mult Scler J Exp Transl Clin
; 6(1): 2055217320901727, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32030197
18.
Anticholinergics for urinary symptoms in multiple sclerosis.
Cochrane Database Syst Rev
; (1): CD004193, 2009 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-19160231
19.
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.
Neurology
; 90(24): e2107-e2118, 2018 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29769373
20.
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.
J Neurosci
; 26(6): 1730-8, 2006 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-16467521